Navigation Links
Mutated gene found in dog disease the same in humans, MU researchers find
Date:4/18/2011

COLUMBIA, Mo. University of Missouri researchers believe both man and animal will benefit from their discovery that the same gene mutation found in Tibetan Terrier dogs can also be found in a fatal human neurological disorder related to Parkinson's disease.

Fabiana Farias, a doctoral candidate in Area Genetics at the University of Missouri, found the mutation as part of her thesis research. Gary Johnson, associate professor of Veterinary Pathobiology; Martin Katz, professor of Veterinary Pathobiology, and Dennis O'Brien, a professor in the Department of Veterinary Medicine and Surgery, along with a host of researchers from MU's College of Veterinary Medicine; College of Agriculture, Food and Natural Resources (CAFNR) and the Mason Eye Institute, recently published the findings in Neurobiology of Disease.

The disease in Tibetian Terriers is called adult-onset neuronal ceroid-lipofuscinosis (NCL). Within the dogs' cells in the brain and eye, material that should be "recycled" builds up and interferes with nerve cell function. Due to this buildup, around the age of five years old, the dog begins to exhibit dementia, impaired visual behavior, loss of coordination, and shows unwarranted aggression.

NCL ultimately took the life of Topper, a Tibetian Terrier owned by Lynn Steinhaus of Columbia. Steinhaus said Topper showed increased shyness around age five, and showed a loss of muscle control later. Topper also suffered seizures before he was euthanized in July of 2009. Topper's DNA was used to further the study.

"This is really hard disease for dog owners to go through," Steinhaus said. "Those seizures are just terrible."

While there are many forms of NCL in humans, the symptoms of NCL are similar in people and dogs, and the disease is ultimately fatal for both. Utilizing the canine genome map and DNA samples from dogs diagnosed with NCL, the researchers were able to pinpoint the specific gene that causes NCL. The mutation they discovered in dogs, however, causes a hereditary form of Parkinson's disease in humans. This suggests that the recycling that goes awry in NCL may also be involved in degenerative diseases like Parkinson's.

Now, DNA from dogs can be tested to identify the presence of the mutated gene, and that test can ensure that Tibetan Terrier breeders do not pass it on to the next generation. The researchers also believe that they may be able to test -potential human therapies on the animal population because they can use the DNA test to identify affected dogs before they start to show symptoms.

"Looking through samples collected from hundreds of dogs over many years, we got to the point where we're able to say this is a disease caused by the mutation of one gene," Katz said. "Finding that gene was like finding a single house in a very large city but we had the dog family history and the tools to look through the city in a systematic way to locate address of the mutation responsible for the disease."

The publication is the result of almost 10 years of work, and the researchers believe it couldn't have occurred without the unique combination of animal and human medical science at the University of Missouri.

"Dogs and people suffer from the same diseases, and it's much easier to discover gene issues in dogs because of the unique genetics of pure-bred dogs," O'Brien said. "Because we have a medical school and veterinary school near each other, we can find the genes in the dog and then find out if they cause a similar disease in people."


'/>"/>

Contact: Steven Adams
AdamsST@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert  

Related medicine news :

1. Single Lung Tumor Contains 50,000 Mutated Genes
2. Targeted drug leads to regression of metastatic melanoma with mutated BRAF gene
3. Mouse model confirms mutated proteins role in dementia
4. When leukemia returns, gene that mediates response to key drug often mutated
5. One-third of antimalarial medicines sampled in 3 African nations found to be substandard
6. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
7. Highmark Foundation Awards $120,000 to the American Heart Association
8. Stuttering Foundation Hails New Research
9. Autism Science Foundation Offers IMFAR Grants to Autism Stakeholders
10. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
11. Corbett Accel Healthcare Group Mourns Passing of Founder Frank J. Corbett
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mutated gene found in dog disease the same in humans, MU researchers find
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... to the Centers for Disease Control and Prevention (CDC), influenza vaccination ... is helping communities across Massachusetts , Connecticut ... flu shots through the end of the month. *Some exclusions ... ... shot is by the end of October, according to the Centers for ...
(Date:10/2/2017)... Oct. 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Software and Consulting, LLC , and named its founder ... based in Tennessee , will operate ... expands EnvoyHealth,s service offerings for health care partners to ... "In an interoperable world, technology ...
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
Breaking Medicine Technology: